Advertisement

Picture AB Sciex Berliner LCMSMS Symposium 2017 Middle 600x60px
Document › Details

Expression Pathology Inc.. (5/15/08). "Press Release: Expression Pathology Obtains SBIR to Identify Protein Biomarkers of Breast Cancer Metastasis". Gaithersburg, MD.

Region Region United States (USA)
Organisations Organisation Expression Pathology Inc. (EPI)
  Today OncoPlex Diagnostics (OncoPlexDx)
  Group OncoPlex Diagnostics (OncoPlexDx)
  Organisation 2 National Cancer Institute (NCI) (US)
  Group United States (govt)
Products Product Liquid Tissue® technology (Expression Pathology)
  Product 2 mass spectrometry (MS)
Index term Index term Expression Pathology–United States (govt): grant, 200805 $148k SBIR Phase I grant from NCI
Person Person Tunon, Peter (Expression Pathology 200501– VP Sales + Marketing)
     


Expression Pathology Inc. (EPI) has been awarded a $148,000
Phase I Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI) to employ its proprietary tissue microproteomics technologies to identify protein biomarkers of metastasis in primary breast cancer. EPI’s Liquid Tissue® sample preparation and Director™ laser microdissection will enable in-depth mass spectrometry based proteomic profiling of archived formalin-fixed tissue with detailed patient histories.

Over 200,000 cases of early-stage breast cancer present for treatment decisions each year in the US. Although gene-expression tests have been developed to help guide those decisions, a protein-based approach has the potential to be more widely available and more informative. Proteins make up the molecular pathways which control cell functions and are the actual targets of most drugs.

“This project is a natural evolution of our business to use our proprietary tissue proteomics research tools to understand at the protein level the progression of metastasis in early-stage breast cancer,” said David Krizman, Ph.D., EPI’s Chief Scientific Officer. “Our aim is to develop valuable tissue protein assays that can aid patient treatment decisions, and to identify new therapeutic targets and companion diagnostics to those targets. We greatly appreciate the NCI’s SBIR program in its support of innovative initiatives by early-stage companies like EPI.”


About Expression Pathology Inc.

EPI is developing proprietary cancer tests and research tools to study and measure proteins in formalin-fixed paraffin-embedded (FFPE) tissue, the format of patient tissue routinely collected and stored in medical treatment and research facilities. FFPE tissue constitutes a huge, untapped resource for discovery, validation and measurement of valuable biomarkers of disease progression, drug response and toxicity.

EPI’s Liquid Tissue® sample preparation and Director™ laser microdissection technologies enable mass spectrometry-based analysis and measurement of proteins in FFPE tissue. EPI offers these as research products, contract services and collaborative research programs. For more information, see
www.expressionpathology.com.

For more information, contact:

Expression Pathology Inc.
Peter Tunon, Vice President Sales and Marketing
9290 Gaither Road
Gaithersburg, MD 20877
Phone: (301) 977-3654
E-mail: p.tunon@expressionpathology.com

   
Record changed: 2016-03-19

Advertisement

Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 600x60px

More documents for OncoPlex Diagnostics (OncoPlexDx)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture AB Sciex Berliner LCMSMS Symposium 2017 Middle 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 120x180px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px